Clene (CLNN) Capital Expenditures (2020 - 2025)
Clene (CLNN) posted Capital Expenditures of $28000.0 for Q4 2025, up 154.55% on a QoQ basis from $11000.0 in Q3 2025, and up 2700.0% year-over-year from $1000.0 in Q4 2024.
Analysis
Clene (CLNN) Capital Expenditures (2020 - 2025) Analysis & Trends
Clene has reported Capital Expenditures for 6 years, with the latest figure at $28000.0 in Q4 2025.
- On a quarterly basis, Capital Expenditures rose 2700.0% year-over-year to $28000.0 in Q4 2025; TTM through Dec 2025 was $39000.0, a 160.0% increase from a year earlier, with the FY2025 full-year figure at $39000.0, up 160.0% from the prior year.
- Capital Expenditures was $28000.0 for Q4 2025 at Clene, up from $11000.0 in the prior quarter.
- The five-year high for Capital Expenditures was $1.7 million in Q4 2022, with the low at -$39000.0 in Q2 2023.
- Average Capital Expenditures over 5 years is $383055.6, with a median of $125500.0 recorded in 2021.
- The sharpest annual moves came in 2023 and 2025: Capital Expenditures plunged 104.39% in 2023, then jumped 2700.0% in 2025.
- Over 5 years, Capital Expenditures stood at $671000.0 in 2021, then jumped by 153.5% to $1.7 million in 2022, then slumped by 97.47% to $43000.0 in 2023, then tumbled by 97.67% to $1000.0 in 2024, then surged by 2700.0% to $28000.0 in 2025.
- The last three Capital Expenditures figures came in at $28000.0 (Q4 2025), $11000.0 (Q3 2025), and $1000.0 (Q4 2024), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capital Expenditures (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 641.14 Bn | 620.38 Bn | 17.26 Bn | 1.32 Bn |
| 2 | AbbVie | 451.04 Bn | 444.47 Bn | 12.70 Bn | 322.00 Mn |
| 3 | Merck | 357.43 Bn | 350.29 Bn | 12.21 Bn | 893.00 Mn |
| 4 | Novartis Ag | 266.73 Bn | 259.04 Bn | 11.24 Bn | -321.00 Mn |
| 5 | Pfizer | 157.52 Bn | 145.82 Bn | 10.94 Bn | 533.00 Mn |
| 6 | Sanofi | 52.14 Bn | 44.76 Bn | 10.79 Bn | - |
| 7 | Revolution Medicines | 42.88 Bn | 42.88 Bn | - | 2.29 Mn |
| 8 | Incyte | 24.70 Bn | 20.16 Bn | 1.57 Bn | 12.41 Mn |
| 9 | United Therapeutics | 21.47 Bn | 18.80 Bn | 683.80 Mn | 108.00 Mn |
| 10 | Clene | 45.69 Mn | 45.69 Mn | 54,000.00 | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | 28,000.00 |
| Sep 30, 2025 | 11,000.00 |
| Dec 31, 2024 | 1,000.00 |
| Sep 30, 2024 | 1,000.00 |
| Jun 30, 2024 | 2,000.00 |
| Mar 31, 2024 | 11,000.00 |
| Dec 31, 2023 | 43,000.00 |
| Sep 30, 2023 | 48,000.00 |
| Jun 30, 2023 | -39,000.00 |
| Mar 31, 2023 | 278,000.00 |
| Dec 31, 2022 | 1.70 Mn |
| Sep 30, 2022 | 1.65 Mn |
| Jun 30, 2022 | 888,000.00 |
| Mar 31, 2022 | 936,000.00 |
| Dec 31, 2021 | 671,000.00 |
| Sep 30, 2021 | 241,000.00 |
| Jun 30, 2021 | 217,000.00 |
| Mar 31, 2021 | 203,000.00 |
| Dec 31, 2020 | 118,000.00 |
| Sep 30, 2020 | 75,000.00 |